logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Prelamin-A/C

UniprotKB/SwissProt ID: LMNA_HUMAN (P02545)

Gene Name: LMNA

Synonyms: LMN1

Organism: Homo sapiens (Human).

Function: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation. Required for osteoblastogenesis and bone formation. Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone. Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Nucleus. Nucleus envelope. Nucleus lamina. Nucleus, nucleoplasm. Note=Farnesylation of prelamin-A/C facilitates nuclear envelope targeting and subsequent cleaveage by ZMPSTE24/FACE1 to remove the farnesyl group produces mature lamin- A/C, which can then

PDB :
( If your security settings prevent Jmol from running, please register http://140.138.144.145/ as a safe location in your Java settings. )

Protein disease:
Disease database Database Entry Disease information
HPRD01035Cardiomyopathy, dilated, 1A
HPRD01035Charcot-Marie-tooth disease, axonal, type 2B1
HPRD01035Emery-Dreifuss muscular dystrophy, autosomal dominant
HPRD01035Emery-Dreifuss muscular dystrophy, autosomal recessive
HPRD01035Hutchinson-Gilford progeria syndrome
HPRD01035Hutchinson-Gilford progeria syndrome, atypical
HPRD01035Lipoatrophy with diabetes, hepatic steatosis, hypertrophic cardiomyopathy, and leukomelanodermic papules
HPRD01035Lipodystrophy, familial partial, type 2
HPRD01035Mandibuloacral dysplasia with type A lipodystrophy
HPRD01035Muscular dystrophy, limb-girdle, type 1B
HPRD01035Myopathy, early-onset, with progeroid features
HPRD01035Restrictive dermopathy, lethal
HPRD01035Werner syndrome, atypical
Network with metabolic pathway:
Kegg map ID Pathway Link
map05412Arrhythmogenic right ventricular cardiomyopathy (ARVC)
map05410Hypertrophic cardiomyopathy (HCM)
map05414Dilated cardiomyopathy
Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR001322
IPR001664

The S-nitrosylation sites of LMNA_HUMAN

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
1522LVWKAQNTWG C GNSLRTALIN EEEECCCCCC C CCCEEEEEEC 3.34%HC0122178444-